Your browser doesn't support javascript.
loading
BRD4 degradation blocks expression of MYC and multiple forms of stem cell resistance in Ph+ chronic myeloid leukemia.
Peter, Barbara; Eisenwort, Gregor; Sadovnik, Irina; Bauer, Karin; Willmann, Michael; Rülicke, Thomas; Berger, Daniela; Stefanzl, Gabriele; Greiner, Georg; Hoermann, Gregor; Keller, Alexandra; Wolf, Dominik; Culen, Martin; Winter, Georg E; Hoffmann, Thomas; Schiefer, Ana-Iris; Sperr, Wolfgang R; Zuber, Johannes; Mayer, Jirí; Valent, Peter.
Afiliação
  • Peter B; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Eisenwort G; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Sadovnik I; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Bauer K; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Willmann M; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Rülicke T; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Berger D; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Stefanzl G; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Greiner G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Hoermann G; Department for Companion Animals and Horses, University Clinic for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Keller A; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Wolf D; Institute of Laboratory Animal Science, University of Veterinary Medicine Vienna, Vienna, Austria.
  • Culen M; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Winter GE; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Hoffmann T; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Schiefer AI; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Sperr WR; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Zuber J; Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria.
  • Mayer J; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Valent P; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Am J Hematol ; 97(9): 1215-1225, 2022 09.
Article em En | MEDLINE | ID: mdl-35794848
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Nucleares / Leucemia Mielogênica Crônica BCR-ABL Positiva Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article